Bone health technologies to present clinical data at ASBMR 2023 from pivotal trial of wearable treatment for osteopenia in post-menopausal women
A pivotal trial of wearable treatment Osteoboost for osteopenia in post-menopausal women showed a significant reduction in vertebral bone strength loss. The study found an average bone strength loss of 0.48% in the Active Treatment group, compared to 2.84% in the Sham group.